Search research articles
Contact Us
Filters
Showing results (21-30 of 35) with videos related to
Page
of 4
Sort By:
The Journal of Urology
|
August 1, 1995
Placebo controlled double-blind study to test the efficacy of the aromatase inhibitor atamestane in patients with benign prostatic hyperplasia not requiring operation. The Schering 90.062 Study Group
J C Gingell, H Knönagel, K H Kurth, et al.
European Urology
|
March 19, 1999
Intermittent complete androgen blockade in PSA relapse after radical prostatectomy and incidental prostate cancer
R Kurek, H Renneberg, G Lübben, et al.
Der Urologe. Ausg. A
|
February 9, 2000
[Intermittent androgen deprivation]
U W Tunn, N Bruchovsky, H Renneberg, et al.
Experimental Nephrology
|
August 18, 1999
Transdifferentiation of distal but not proximal tubular epithelial cells from human kidney in culture
P C Baer, U W Tunn, G Nunez, et al.
BJU International
|
January 5, 2000
The significance of serum levels of insulin-like growth factor-1 in patients with prostate cancer
R Kurek, U W Tunn, O Eckart, et al.
Urologia Internationalis
|
May 1, 1998
Comparison of LH-RH analogue 1-month depot and 3-month depot by their hormone levels and pharmacokinetic profile in patients with advanced prostate cancer
U W Tunn, U Bargelloni, S Cosciani, et al.
Investigative Urology
|
January 1, 1981
Morphometric analysis of prostates in castrated dogs after treatment with androstanediol, estradiol, and cyproterone acetate
U W Tunn, B Schüring, T Senge, et al.
Urological Research
|
March 26, 1999
Prostate specific membrane antigen (PSM) is expressed in various human tissues: implication for the use of PSM reverse transcription polymerase chain reaction to detect hematogenous prostate cancer spread
H Renneberg, A Friedetzky, L Konrad, et al.
The Journal of Urology
|
December 1, 1993
Mitomycin C versus estramustine in the treatment of hormone resistant metastatic prostate cancer: the final analysis of the European Organization for Research and Treatment of Cancer, genitourinary group prospective randomized phase III study (30865)
D W Newling, S D Fossa, U W Tunn, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
March 1, 1993
Management of benign prostatic hyperplasia with particular emphasis on aromatase inhibitors
U F Habenicht, U W Tunn, T Senge, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 35) with videos related to
Sort By:
Page
of 4
The Journal of Urology
|
August 1, 1995
Placebo controlled double-blind study to test the efficacy of the aromatase inhibitor atamestane in patients with benign prostatic hyperplasia not requiring operation. The Schering 90.062 Study Group
J C Gingell, H Knönagel, K H Kurth, et al.
European Urology
|
March 19, 1999
Intermittent complete androgen blockade in PSA relapse after radical prostatectomy and incidental prostate cancer
R Kurek, H Renneberg, G Lübben, et al.
Der Urologe. Ausg. A
|
February 9, 2000
[Intermittent androgen deprivation]
U W Tunn, N Bruchovsky, H Renneberg, et al.
Experimental Nephrology
|
August 18, 1999
Transdifferentiation of distal but not proximal tubular epithelial cells from human kidney in culture
P C Baer, U W Tunn, G Nunez, et al.
BJU International
|
January 5, 2000
The significance of serum levels of insulin-like growth factor-1 in patients with prostate cancer
R Kurek, U W Tunn, O Eckart, et al.
Urologia Internationalis
|
May 1, 1998
Comparison of LH-RH analogue 1-month depot and 3-month depot by their hormone levels and pharmacokinetic profile in patients with advanced prostate cancer
U W Tunn, U Bargelloni, S Cosciani, et al.
Investigative Urology
|
January 1, 1981
Morphometric analysis of prostates in castrated dogs after treatment with androstanediol, estradiol, and cyproterone acetate
U W Tunn, B Schüring, T Senge, et al.
Urological Research
|
March 26, 1999
Prostate specific membrane antigen (PSM) is expressed in various human tissues: implication for the use of PSM reverse transcription polymerase chain reaction to detect hematogenous prostate cancer spread
H Renneberg, A Friedetzky, L Konrad, et al.
The Journal of Urology
|
December 1, 1993
Mitomycin C versus estramustine in the treatment of hormone resistant metastatic prostate cancer: the final analysis of the European Organization for Research and Treatment of Cancer, genitourinary group prospective randomized phase III study (30865)
D W Newling, S D Fossa, U W Tunn, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
March 1, 1993
Management of benign prostatic hyperplasia with particular emphasis on aromatase inhibitors
U F Habenicht, U W Tunn, T Senge, et al.
Page
of 4